Overview
A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure
Status:
Completed
Completed
Trial end date:
2008-01-28
2008-01-28
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the safety and blood pressure lowering effect of different doses of PF-00489791 in patients with mild to moderate high blood pressurePhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:1. Males and/or Females of non-childbearing potential between 18 and 70 years of age
2. History of mild to moderate hypertension
Exclusion Criteria:
1. Type 1 or 2 diabetes on prescribed medications
2. Secondary, severe, or malignant hypertension
3. History of a significant cardiovascular event within the last 12 months of enrollment